EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

0534 Efficacy and safety of switching from reference ustekinumab to its biosimilar for the treatment of plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials

L. Ghanem, M. Cevallos-Cueva, N. Kirmani, S. Aktas, L. Fenalte Streher, A. Santros, C. Montes de Oca Saucedo

Journal of Investigative Dermatology · 2026-08 · 146 (8) · S92

DOI: 10.1016/j.jid.2026.06.565 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von L. Ghanem und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ghanem, L., Cevallos-Cueva, M., Kirmani, N., Aktas, S., Streher, L. F., Santros, A., & Saucedo, C. M. D. O. (2026). 0534 Efficacy and safety of switching from reference ustekinumab to its biosimilar for the treatment of plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials. Journal of Investigative Dermatology, 146(8), S92. https://doi.org/10.1016/j.jid.2026.06.565

Vancouver

Ghanem L, Cevallos-Cueva M, Kirmani N, Aktas S, Streher LF, Santros A, et al. 0534 Efficacy and safety of switching from reference ustekinumab to its biosimilar for the treatment of plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials. Journal of Investigative Dermatology. 2026;146(8):S92. doi:10.1016/j.jid.2026.06.565

BibTeX
@article{Ghanem2026,
  author = {Ghanem, L. and Cevallos-Cueva, M. and Kirmani, N. and Aktas, S. and Streher, L. Fenalte and Santros, A. and Saucedo, C. Montes de Oca},
  title = {0534 Efficacy and safety of switching from reference ustekinumab to its biosimilar for the treatment of plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials},
  journal = {Journal of Investigative Dermatology},
  year = {2026},
  volume = {146},
  number = {8},
  pages = {S92},
  doi = {10.1016/j.jid.2026.06.565}
}
Kostenlos starten →